TP53 and leukemia: Taken together, our data indicate that FLT3-ITD and p53 KO synergistically enhance the expression of Htra3 and reduce the expression of Lin28a, leading to leukemia development by increased proliferation, reduced apoptosis, and enhanced block of differentiation, but without increasing the self-renewal activity.